These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 23041156)
1. Extracellular and intracellular esterase processing of SCFA-hexosamine analogs: implications for metabolic glycoengineering and drug delivery. Mathew MP; Tan E; Shah S; Bhattacharya R; Adam Meledeo M; Huang J; Espinoza FA; Yarema KJ Bioorg Med Chem Lett; 2012 Nov; 22(22):6929-33. PubMed ID: 23041156 [TBL] [Abstract][Full Text] [Related]
2. Glycoengineering of Esterase Activity through Metabolic Flux-Based Modulation of Sialic Acid. Mathew MP; Tan E; Labonte JW; Shah S; Saeui CT; Liu L; Bhattacharya R; Bovonratwet P; Gray JJ; Yarema KJ Chembiochem; 2017 Jul; 18(13):1204-1215. PubMed ID: 28218815 [TBL] [Abstract][Full Text] [Related]
6. Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery. Elmouelhi N; Aich U; Paruchuri VD; Meledeo MA; Campbell CT; Wang JJ; Srinivas R; Khanna HS; Yarema KJ J Med Chem; 2009 Apr; 52(8):2515-30. PubMed ID: 19326913 [TBL] [Abstract][Full Text] [Related]
7. Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes. Saeui CT; Nairn AV; Galizzi M; Douville C; Gowda P; Park M; Dharmarha V; Shah SR; Clarke A; Austin M; Moremen KW; Yarema KJ PLoS One; 2018; 13(5):e0195812. PubMed ID: 29847599 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological, Physiochemical, and Drug-Relevant Biological Properties of Short Chain Fatty Acid Hexosamine Analogues Used in Metabolic Glycoengineering. Saeui CT; Liu L; Urias E; Morrissette-McAlmon J; Bhattacharya R; Yarema KJ Mol Pharm; 2018 Mar; 15(3):705-720. PubMed ID: 28853901 [TBL] [Abstract][Full Text] [Related]
9. Characterization of the metabolic flux and apoptotic effects of O-hydroxyl- and N-acyl-modified N-acetylmannosamine analogs in Jurkat cells. Kim EJ; Sampathkumar SG; Jones MB; Rhee JK; Baskaran G; Goon S; Yarema KJ J Biol Chem; 2004 Apr; 279(18):18342-52. PubMed ID: 14966124 [TBL] [Abstract][Full Text] [Related]
10. Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogues inhibits the mobility of metastatic MDA-MB-231 breast cancer cells. Campbell CT; Aich U; Weier CA; Wang JJ; Choi SS; Wen MM; Maisel K; Sampathkumar SG; Yarema KJ J Med Chem; 2008 Dec; 51(24):8135-47. PubMed ID: 19053749 [TBL] [Abstract][Full Text] [Related]
12. Development of delivery methods for carbohydrate-based drugs: controlled release of biologically-active short chain fatty acid-hexosamine analogs. Aich U; Meledeo MA; Sampathkumar SG; Fu J; Jones MB; Weier CA; Chung SY; Tang BC; Yang M; Hanes J; Yarema KJ Glycoconj J; 2010 May; 27(4):445-59. PubMed ID: 20458533 [TBL] [Abstract][Full Text] [Related]
13. Glycoengineering Human Neural and Adipose Stem Cells with Novel Thiol-Modified Du J; Agatemor C; Saeui CT; Bhattacharya R; Jia X; Yarema KJ Cells; 2021 Feb; 10(2):. PubMed ID: 33673061 [TBL] [Abstract][Full Text] [Related]
14. Metabolic Glycoengineering with Azide- and Alkene-Modified Hexosamines: Quantification of Sialic Acid Levels. Dold JEGA; Wittmann V Chembiochem; 2021 Apr; 22(7):1243-1251. PubMed ID: 33180370 [TBL] [Abstract][Full Text] [Related]
15. Engineering sialic acid synthetic ability into insect cells: identifying metabolic bottlenecks and devising strategies to overcome them. Viswanathan K; Lawrence S; Hinderlich S; Yarema KJ; Lee YC; Betenbaugh MJ Biochemistry; 2003 Dec; 42(51):15215-25. PubMed ID: 14690432 [TBL] [Abstract][Full Text] [Related]
16. Characterization of ligand binding to the bifunctional key enzyme in the sialic acid biosynthesis by NMR: II. Investigation of the ManNAc kinase functionality. Benie AJ; Blume A; Schmidt RR; Reutter W; Hinderlich S; Peters T J Biol Chem; 2004 Dec; 279(53):55722-7. PubMed ID: 15498763 [TBL] [Abstract][Full Text] [Related]
17. Hexosamine analogs: from metabolic glycoengineering to drug discovery. Wang Z; Du J; Che PL; Meledeo MA; Yarema KJ Curr Opin Chem Biol; 2009 Dec; 13(5-6):565-72. PubMed ID: 19747874 [TBL] [Abstract][Full Text] [Related]
18. Convergent pathways for utilization of the amino sugars N-acetylglucosamine, N-acetylmannosamine, and N-acetylneuraminic acid by Escherichia coli. Plumbridge J; Vimr E J Bacteriol; 1999 Jan; 181(1):47-54. PubMed ID: 9864311 [TBL] [Abstract][Full Text] [Related]
19. A novel sugar analog enhances sialic acid production and biotherapeutic sialylation in CHO cells. Yin B; Wang Q; Chung CY; Bhattacharya R; Ren X; Tang J; Yarema KJ; Betenbaugh MJ Biotechnol Bioeng; 2017 Aug; 114(8):1899-1902. PubMed ID: 28295160 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of non-natural ManNAc analogs for the expression of thiols on cell-surface sialic acids. Sampathkumar SG; Li AV; Yarema KJ Nat Protoc; 2006; 1(5):2377-85. PubMed ID: 17406481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]